Spreadsheet: 3bb78e11-cf97-4408-97b5-210a187aec61
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
IGF1I | Test | IGF1I | Insulin-Like Growth Factor 1, Serum | Insulin-Like Growth Factor 1, S | Chemiluminescence | Serum Gel Tube: SGT |  |  | 0.5 | mL | Collection Container/Tube: Preferred: Red top Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 0.5 mL Collection Instructions: Spin down promptly. Additional Information: Indicate patient's age and sex. Forms: If not ordering electronically, submit a General Request Form (Supply T239) with the specimen. | 0.25 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK  Lipemia	Mild OK; [NAME] OK Icterus	NA Other	NA | Males: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	15-150	3 1 year	18-179	4 2 years	22-204	5 3 years	25-224	6 4 years	28-241	8 5 years	32-259	9 6 years	36-281	11 7 years	42-311	13 8 years	49-351	16 9 years	58-401	19 10 years	70-458	24 11 years	82-516	29 12 years	93-567	35 13 years	103-603	41 14 years	111-620	46 15 years	115-618	50 16 years	115-598	52 17 years	113-566	54 18 years	109-527	  19 years	104-484	  20 years	98-443	  21-25 years	83-344	  26-30 years	75-275	  31-35 years	71-241	  36-40 years	69-226	  41-45 years	64-210	  46-50 years	59-201	  51-55 years	56-201	  56-60 years	51-194	  61-65 years	47-191	  66-70 years	46-195	  71-75 years	42-187	  76-80 years	39-184	  80-85 years	37-182	  85-90 years	35-182	    Females: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	18-146	5 1 year	20-159	6 2 years	23-177	7 3 years	27-198	8 4 years	32-223	10 5 years	36-246	12 6 years	41-269	15 7 years	48-299	17 8 years	56-339	21 9 years	68-396	26 10 years	83-465	32 11 years	99-537	40 12 years	115-598	48 13 years	126-637	56 14 years	133-647	62 15 years	134-631	65 16 years	130-595	66 17 years	123-546	64 18 years	114-493	  19 years	105-441	  20 years	97-398	  21-25 years	84-323	  26-30 years	77-271	  31-35 years	73-244	  36-40 years	68-225	  41-45 years	62-205	  46-50 years	56-194	  51-55 years	53-191	  56-60 years	45-173	  61-65 years	41-168	  66-70 years	39-168	  71-75 years	36-166	  76-80 years	35-168	  80-85 years	35-179	  85-90 years	33-179	  Reference values have not been established for patients that are >90 years of age.   IGF-1 reference values according to Tanner stages I-V(2) Males Stage I: 83-255 ng/mL Stage II: 114-440 ng/mL Stage III: 236-516 ng/mL Stage IV: 218-580 ng/mL Stage V: 229-522 ng/mL Females Stage I: 90-324 ng/mL Stage II: 104-456 ng/mL Stage III: 249-519 ng/mL Stage IV: 238-574 ng/mL Stage V: 187-509 ng/mL   Note: Puberty onset, ie the transition from Tanner stage 1 (prepubertal) to Tanner stage 2 (early pubertal), occurs for girls at a median age of 10.5 (+/-2) years and for boys at a median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African-American girls. By contrast, for boys there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage 5 (young adult) should be reached by age 18. | Monday through Friday; 5 a.m.-12a.m., Saturday; 6 a.m.-6 p.m. | Same day/1 day | 3 days | 1 | 84305 |  |  |  |  | Rochester
IGF1I | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
IGF1I | Result | IGF1I | Insulin-Like Growth Factor 1, S | Insulin-Like Growth Factor 1, S | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 2484-4